side effects glp 1 agonist of liraglutide (GLP-1 receptor agonist) – Efficacy and Adverse common side effects of GLP-1
Description
Kastin AJ, Akerstrom V
Wegovy, in May 2024, was approved by the F.D.A
Benefits for T1D There are both long and short-term benefits to using this class of medications for PWD, which often outweigh the challenges
As of April 2026, both semaglutide and tirzepatide remain on the shortage list, which permits compounding
GLP-1 receptor agonists should be considered in patients with type II diabetes and high ASCVD risk OR patients without diabetes who are overweight/obese and have a history of cardiovascular disease
Lancet 330, 13001304
